In Brief: Guidant Mini III
This article was originally published in The Gray Sheet
Executive Summary
Guidant Mini III: Shipments of the 48 cc, 90 g single chamber pacer/implantable cardioverter defibrillator are anticipated to commence in March. Guidant received FDA approval via premarket approval application supplement on Jan. 23 and will ramp up manufacturing capability prior to shipping, the firm states. The device is a smaller version of the firm's 59 cc, 115 g Mini II, and incorporates Guidant's new Quick Check and Quick Notes features which "allow the clinician to easily and quickly perform a comprehensive series of automatic tests and follow-up device operations" to facilitate patient management, Guidant states. The device uses Guidant's Endotak lead and Triad three-electrode energy defibrillation system...